About
Prior to co-founding Aviara, George served 9 years at Encysive Pharmaceuticals, Inc. (formerly Texas Biotechnology Corp.) where he was Vice President of Chemical Sciences. Previous to Encysive, Dr. Holland was for 26 years with Hoffmann-La Roche (Nutley) where he served both as senior therapeutic area management and leader of medicinal/synthetic chemistry groups working on a broad range of synthetic and therapeutic targets. At Encysive he was involved in all phases of the drug discovery and development effort that resulted in the regulatory approval and commercialization of the endothelin antagonist Thelin™ in North America, Europe and Australia. Dr. Holland has more than 36 publications and 50 patents. He earned a PhD in organic chemistry from the Iowa State University and conducted postdoctoral studies at Purdue University with Nobel Laureate Herbert C. Brown.
Investment Focus
- Location
- Houston, US
Contact Information
Find more investors like George
Search Investors